Tumor Diagnosis Using Electrophoretic Mobility Test (EMT)

Review on State of the Art with Reference to the Use of Stabilized Erythrocytes as Indicator Particles


There is still a major need for better tools for early detection of the presence of a tumor. Immunologic approaches are such potential tools for diagnosis of human cancer; they are sensitive and specific.


Electrophoretic Mobility Migration Inhibition Factor Basic Myelin Protein Indicator Cell Peritoneal Exudate Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    AMBROSE, E.J.: Cell Electrophoresis. Ambrose, E.J. (ed.) London: Churchill 1965Google Scholar
  2. 2.
    AX, W. et al.: unpublished dataGoogle Scholar
  3. 3.
    CARNEGIE, R.P., CASPARY, E.A., DICKINSON, J.P., FIELD, E.J.: The macrophage electrophoretic migration (MEM) test for lymphocyte sensitization. Clin. Exp. Immunol. 14, 37 (1973)PubMedGoogle Scholar
  4. 4.
    CASPARY, E.A.: The mechanism of antigen induced electrophoretic mobility reduction of guinea-pig macropahges. Clin. Exp. Immunol. 11, 305 (1972)PubMedGoogle Scholar
  5. 5.
    CASPARY, E.A., FIELD, E.J.: Specific lymphocyte sensitization in cancer: Is there a common antigen in human malignant neoplasia? Br. Med. J. 1971, 2, 613CrossRefPubMedGoogle Scholar
  6. 6.
    COCHRAN, A.J., SPILG, W.G., MACKIE, R.M., THOMAS, C.E.: Postoperative depression of tumor-directed cell-mediated immunity in patients with malignant disease. Br. Med. 4, 67 (1972)CrossRefGoogle Scholar
  7. 7.
    CROZIER, E.H., HOLLINGER, M.E., WOODEND, B.E., ROBERTSON, J.H.: J. Clin. Pathol. 29, 608 (1976)CrossRefPubMedGoogle Scholar
  8. 8.
    DAVID, J.R., AL-ASKARI, S., LAWRENCE, H.H., THOMAS, L.: Delayed hypersensitivity in vitro. I. The specifictiy of inhibition of cell migration by antigens. J. Immunol. 93, 264 (1974)Google Scholar
  9. 9.
    DICKINSON, J.P., CASPARY, E.A., FIELD, E.J.: A common tumor specific antigen. I. Restriction in vivo to malignant neoplastic tissue. Br. J. Cancer 27, 99 (1973)CrossRefPubMedGoogle Scholar
  10. 10.
    DIENGDOH, J.V., TURK, J.L.: Electrophoretic mobility of guinea-pig peritoneal exudate cells in hypersensitivity reactions. Int. Arch. Allergy 34, 297 (1968)CrossRefPubMedGoogle Scholar
  11. 11.
    DOBROSCHKE, J., VöLKEL, W., AX, W., GIERHAKE, F.W., SCHWEMMLE, K.: Electrophoretic mobility test in early tumor diagnosis. Soc. Int. de Chir. 27th Congress, Kyoto (1977)Google Scholar
  12. 12.
    DOUWES, F.R., HANKE, R., MROSS, K.: Der Elektrophorese-Mobilitätstest in der Diagnostik von Malignomen. Z. Krebsforsch. 87, 281 (1976)CrossRefGoogle Scholar
  13. 13.
    DOUWES, F.R., HüTTEMANN, U., MROSS, K.: Immundiagnostik maligner Erkrankungen. Dtsch. Med. Wochenschr. 102, 418 (1977a)Google Scholar
  14. 14.
    DOUWES, F.R., HOFFMANN, W., MROSS, K.: Immundiagnostics of malignant diseases. II. The electrophoretic mobility test in the diagnosis of gynecological malignancies. Oncologie 34, 80 (1977b)CrossRefGoogle Scholar
  15. 15.
    DOUWES, F., HOFFMANN, W., SCHMOLL, H.J., MROSS, K.: The electrophoretic mobility test in the diagnosis of urological malignancies. 3rd Asian Cancer Conference, Manila (1977c)Google Scholar
  16. 16.
    ENGLISH, D., ANDERSON, B.R.; Single step separation of red blood cells, granulocytes and mononuclear microcytes on discontinuous density gradients of Ficoll Hypaque. J. Immunol. Methods 5, 249 (1974)CrossRefPubMedGoogle Scholar
  17. 17.
    FIELD, E.J., CASPARY, E.A.: Lymphocyte sensitization; An in vitro test for cancer? Lancet 1970, 2, 1337CrossRefPubMedGoogle Scholar
  18. 18.
    FIELD, E.J., CASPARY, E.A., CARNEGIE, P.R.: Lymphocyte sensitization to basic protein of brain in malignant neoplasia: Experiments with serotonin and related compounds. Nature (London) 233, 284 (1971)CrossRefGoogle Scholar
  19. 19.
    FIELD, E.J., CASPARY, E.A., HALL, R., CLARK, F.: Circulating sensitized lymphocytes in Graves’ disease. Observation on its pathogenesis. Lancet 1970, I, 1144CrossRefGoogle Scholar
  20. 20.
    FIELD, E.J., CASPARY, E.A.: Lymphocyte sensitization to carcino-embryonic antigen (Gold) with special reference to multiple sclerosis. Br. Med. J. 4, 261 (1972)CrossRefPubMedGoogle Scholar
  21. 21.
    FIELD, E.J., BATES, D., SHAW, D.A., GRIFFIN, S.G., SHENTON, B.K., SMITH, K.: Lymphocyte sensitization in myasthenia gravis: Function of the adult thymus gland. Lancet 1973, 22, 675CrossRefGoogle Scholar
  22. 22.
    FIELD, E.J., SHENTON, B.K., MEYER-RIENECKER, H.J., JENSSEN, H.L., KöHLER, H., GüNTHER, K., FRIEMEL, H.: Die Makrophagen-Elektro-phorese-Mobilitäts-(MEM)Methode: ihre Anwendung in der klinischen Immunologie. Dtsch. Gesundheitswes. 30, 377 (1975)Google Scholar
  23. 23.
    FUHRMANN, C.F., Ruhenstroth-Bauer: Cell electrophoresis employing a rectangular measuring cuvette. In: Cell electrophoresis, Ambrose, E.J. (ed.). London: Churchill 1965Google Scholar
  24. 24.
    HANNIG, K.: Personal communicationGoogle Scholar
  25. 25.
    HELLSTRöM, I., HELLSTRöM, K.E., SJöRGREN, H.O., WARNER, G.A.: Demonstration of cell-mediated immunity to human neoplasma of various histological type. Int. J. Cancer 7, 1–16 (1971)CrossRefPubMedGoogle Scholar
  26. 26.
    HERBERMAN, R.B.: Immunologic approaches to the diagnosis of cancer. Cancer 37, 549 (1976)CrossRefPubMedGoogle Scholar
  27. 27.
    HERBERMAN, R.B., HOLLINSHEAD, A.C., ALFORD, T.C., McCOY, J.L., HALTERMANN, R.H., LEVENTHAL, B.C.: Delayed cutaneous hypersensitivity reactions to extracts of human tumors. Natl. Cancer Inst. Monogr. 37, 189 (1973)PubMedGoogle Scholar
  28. 28.
    HUGHES, D., CASPARY, E.A., FIELD, E.J.: Delayed hypersensitivity studies in experimental allergic encephalomyelitis; a comparison of macrophage migration inhibition test and electrophoretic mobility. Z. Immunol. Forsch. 141, 14 (1970)Google Scholar
  29. 29.
    IRMSCHER, J., MüLLER, M., FISCHER, G., OTTO, G., STRIETZEL, M.: Makrophagen-Elektrophorese-Mobilitäts-Test (MEM) zur immunologischen Diagnose maligner Geschwülste. Dtsch. Gesundheitswes. 30, 687 (1975)Google Scholar
  30. 30.
    JENSSEN, H.L., KöHLER, H., GüNTHER, J., KLAUSCH, B., STRAUBE, W., HOFMANN, R., BüTTNER, H.H.: Macrophage electrophoretic mobility (MEM) test in malignant gynaecological diseases. Arch. Gynäkol. 220, 191 (1976)CrossRefPubMedGoogle Scholar
  31. 31.
    KOTZSCH, M., IRMSCHER, J., FISCHER, R., HEIDL, G., MüLLER, M.: Untersuchungen zur immunologischen Spezifität des Makrophagen-Elektrophorese-Mobilitätstests bei Mäusen mit syngenen und allogenen Mammakarzinom-Transplantaten. Acta Biol. Med. Ger. 35, 1749 (1976)PubMedGoogle Scholar
  32. 32.
    LäMPERT, F., NITZSCHKE, U., ZWERGEL, T.: Lymphocyte sensitization in childhood solid tumours and lymphoblastic leukemia, measured by electrophoretic mobility test. Br. J. Cancer 35, 844 (1977)CrossRefPubMedGoogle Scholar
  33. 33.
    LEWKONIA, R.M., KERR, E.J.L., IRVINE, W.J.: Clinical evaluation of the macrophage electrophoretic mobility test for cancer. Br. J. Cancer 30, 532 (1974)CrossRefPubMedGoogle Scholar
  34. 34.
    MALUISH, A., HALLIDAY, W.J.: Cell-mediated immunity and specific serum factors in human cancer: The leukocyte adherence inhibition test. J. Natl. Cancer Inst. 52, 1415 (1974)PubMedGoogle Scholar
  35. 35.
    MüLLER, M., IRMSCHER, J., FISCHER, R., GROSSMANN, H.: Immunologisches Tumorprofil. Dtsch. Gesundheitswes. 30, 1836 (1975)Google Scholar
  36. 36.
    MüLLER, M., IRMSCHER, J., FISCHER, R., HEIDL, G., GROSSMANN, H.: Immunological tumour profile: Organ-specific carcinoma diagnosis in patients employing the macrophage electrophoretic mobility test. Cancer Lett. 2, 139 (1977)CrossRefPubMedGoogle Scholar
  37. 37.
    NITZSCHKE, U., ZWERGEL, T., LAMPERT, F.: Electrophoretic mobility (EM test for childhood cancer diagnosis. Eur. J. Pediatr. 126, 136 (1977)CrossRefGoogle Scholar
  38. 38.
    PASTERNAK, L., JENSSEN, H.L., KöHLER, H., PASTERNAK, G.: Cross-reactions among mouse tumors of different etiology as detected by macrophage electrophoretic mobility (MEM) test. Eur. J. Cancer 12, 389 (1976)CrossRefPubMedGoogle Scholar
  39. 39.
    PORZSOLT, F., TAUTZ, Ch., AX, W.: Electrophoretic mobility test: I. Modificationsto simplify the detection of malignant diseases in man. Behring Inst. Mitt., No. 57, 128 (1975)Google Scholar
  40. 40.
    PORZSOLT, F., TAUTZ, Ch., SCHMIDTBERGER, R., AX, W.: Zellelektro-phoretische Untersuchungen zur Tumordiagnostik. Z. Immunitätsforsch. 147, 352 (1974)Google Scholar
  41. 41.
    PORZSOLT, F., MüHLBERGER, G., AX, W.: Electrophoretic mobility test (EM): II. Is there a correlation between the clinical diagnosis and immunologic test for precancerous diseases? Behring Inst. Mitt., No. 57, 137 (1975)Google Scholar
  42. 42.
    PRECHTEL, K.: Beziehung der Mastopathie zum Mammkarzinom. Fortschr. Med. 2, 43 (1972)CrossRefGoogle Scholar
  43. 43.
    PREECE, A.W., LIGHT, A.P.: The macrophage electrophoretic mobility test for malignant disease. Clin. Exp. Immunol. 18, 543 (1974)PubMedGoogle Scholar
  44. 44.
    PRITCHARD, J.A.V., MOORE, J.L., SUTHERLAND, W.H., JOSLIN, C.A.F.: Technical aspects of the macrophage electrophoretic mobility (MEM) test for malignant disease. Br. J. Cancer 28, Suppl. I, 299 (1973)Google Scholar
  45. 45.
    RAM, H.S.A., OTIKO, G., WINDER, A.F.: Evaluation of macrophage electrophoretic mobility (MEM) test as an indicator of cellular immunity in ocular tumours. Br. J. Opthalmol. 60, 589 (1976)CrossRefGoogle Scholar
  46. 46.
    SHAW, A., ETTIN, G., McPHERSON, T.A.: Response of cancer patients in the MEM test: Not just a function of charge on basic proteins. Br. J. Cancer 34, 7 (1976)CrossRefPubMedGoogle Scholar
  47. 47.
    SHENTON, B.K., JENSSEN, H.L., WERNER, H., FIELD, E.J.: A comparison of the kinetics of the macrophage electrophoretic mobility (MEM) and the tanned sheep erythrocyte electrophoretic mobility (TEEM) tests. J. Immunol. Methods 14, 123 (1977)CrossRefPubMedGoogle Scholar
  48. 48.
    SINGER, A., SHELTON, J., HILL, S., POTTER, Ch.: Cellular immunity to human basic myelin protein in women with dysplasia and carcinoma in situ of the cervix. Br. J. Obstet. Gynaecol. 82, 820 (1975)CrossRefPubMedGoogle Scholar
  49. 49.
    SMITH, B.A., WARE, B.R., WEINER, R.S.: Electrophoretic distribution of human peripheral blood mononuclear white cells from normal subjects and from patients with acute lymphocytic leukaemia. Proc. Natl. Acad. Sci. USA 73, 238 (1976)CrossRefGoogle Scholar
  50. 50.
    TAUTZ, Ch., LAIER, E., SCHNEIDER, W.: Der MEM-Test, ein hochsensibler Malignom-Test. Monatsschr. Kinderheilkd. 125, 456 (1977)PubMedGoogle Scholar
  51. 51.
    TAUTZ, Ch., SCHNEIDER, W., LAIER, E., BRüGMäNN, G.: Der Elektro-phorese-Mobilitäts-Test: Untersuchungsmethode zur Unterscheidung von malignen und nicht malignen Tumoren. Klin. Wochenschr. (In press)Google Scholar
  52. 52.
    UZGIRIS, E.E., KAPLAN, J.H.: Study of lymphocyte and erythrocyte electrophoretic mobility by Laser Doppler Spectroscopy. Anal. Biochem. 60, 455 (1974)CrossRefPubMedGoogle Scholar
  53. 53.
    WALCH, G.: Der EMT in der Diagnose des Mamma-Ca. Dissertation University Marburg (1976)Google Scholar
  54. 54.
    Workshop on macrophage electrophoretic mobility (MEM) and structuredness of cytoplasmic matrix (SDM) tests. Reported by K.D. Bagshawe. Br. J. Cancer 35, 701 (1977)Google Scholar
  55. 55.
    ZWERGEL, Th. NITZSCHKE, U., BROCKMEIER, D., LAMPERT, F.: Technische Verbesserungen des EM-Tests für den klinischen Routineeinsatz. 74. Tagung, Dtsch. Ges. Kinderheilkd. Kiel (1977)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1979

Authors and Affiliations

  • W. Ax
    • 1
  1. 1.Behringwerke AGMarburg/LahnGermany

Personalised recommendations